Incyte to Report Fourth Quarter and Year-End Financial Results
WILMINGTON, Del.--(BUSINESS WIRE)--Jan 23, 2020--
Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2019 financial results conference call and webcast for 8:00 a.m. ET on Thursday, February 13, 2020.
The schedule for the press release and conference call/webcast is as follows:
February 13, 2020 at 7:00 a.m. ET
February 13, 2020 at 8:00 a.m. ET
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415 . To access the replay you will need the conference ID number 13698234.
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200123005007/en/
CONTACT: Incyte Contacts
Catalina Loveman +1 302 498 6171
Michael Booth, DPhil +1 302 498 5914
KEYWORD: UNITED STATES NORTH AMERICA DELAWARE
INDUSTRY KEYWORD: PROFESSIONAL SERVICES HEALTH FINANCE GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY
Copyright Business Wire 2020.
PUB: 01/23/2020 08:00 AM/DISC: 01/23/2020 08:01 AM